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The relationship between dendritic cells (DCs) and
commensal microflora in shaping systemic immune
responses is not well understood. Here, we report
that mice deficient for the Fas-associated death
domain in DCs developed systemic inflammation
associated with elevated proinflammatory cytokines
and increased myeloid and B cells. These mice
exhibited reduced DCs in gut-associated lymphoid
tissues due to RIP3-dependent necroptosis,
whereas DC functions remained intact. Induction of
systemic inflammation required DC necroptosis and
commensal microbiota signals that activated
MyD88-dependent pathways in other cell types. Sys-
temic inflammation was abrogated with the adminis-
tration of broad-spectrum antibiotics or complete,
but not DC-specific, deletion of MyD88. Thus, we
have identified a previously unappreciated role for
commensal microbiota in priming immune cells for
inflammatory responses against necrotic cells.
These studies demonstrate the impact intestinal
microflora have on the immune system and their
role in eliciting proper immune responses to harmful
stimuli.INTRODUCTION
Successful immunity relies on the ability of dendritic cells (DCs)
to recognize pathogens, secrete inflammatory cytokines, and
present antigens to initiate T cell activation (Banchereau et al.,
2000). DCs are present in all tissues and survey their environ-
ment to induce protection against infectious agents or tolerance
to self-antigens. This is particularly important in the intestinal mu-
cosa where DCs constantly encounter microbes and other
foreign antigens. The intestinal microenvironment and
commensal microbiota interactions help dictate intestinal DC
functions, thereby influencing the functions of other immune
cell populations (Coombes and Powrie, 2008; Scott et al.,
2011). Thus, the strict regulation of DC activities is important in
executing proper immune responses. DC development depends1932 Cell Reports 3, 1932–1944, June 27, 2013 ª2013 The Authorson the cytokine fms-like tyrosine receptor kinase 3 ligand (Flt-3L)
(Karsunky et al., 2003; McKenna et al., 2000; Waskow et al.,
2008), whereas cellular homeostasis in the periphery is main-
tained by processes like apoptosis to prevent disease develop-
ment (Kushwah and Hu, 2010). DCs commonly undergo
apoptosis following antigen presentation to T cells to limit im-
mune responses. Inhibition of apoptosis in DCs triggers the
development of systemic autoimmune disease (Chen et al.,
2006; Mabrouk et al., 2008; Stranges et al., 2007).
The adaptor protein Fas-associated death domain (FADD)
plays a crucial role downstream of all death receptors in the in-
duction of apoptosis (Yeh et al., 1998; Zhang et al., 1998). The
tumor necrosis factor (TNF) superfamily of death receptors,
including CD95 (Fas), TNF receptor type I (TNF-RI), and TNF-
related apoptosis-inducing ligand receptor (TRAIL-R), initiate
cell death by recruiting FADD and the protease caspase-8 into
a complex, resulting in a cascade of protease activation and
eventual cell death (Strasser et al., 2009; Wilson et al., 2009).
More recent studies, however, have focused on an alternative
form of cell death, termed necroptosis or programmed necrosis,
that can be initiated by death receptor signaling when apoptosis
is blocked (Degterev et al., 2005, 2008; Moquin and Chan, 2010).
Necroptosis requires the kinase activities of the death domain
containing kinase RIP1 and its family member RIP3, which
interact through their RIP homotypic interaction motif (Cho
et al., 2009; He et al., 2009; Sun et al., 1999). Thus, direct inhibi-
tion of the RIP1 kinase activity with a small molecule inhibitor,
necrostatin-1 (Nec-1) or targeted deletion of RIP3 can block nec-
roptosis (Degterev et al., 2005, 2008). Recent reports have
demonstrated a role for FADD in regulating necroptosis. In the
absence of FADD, depending on the tissues being affected, nec-
roptosis occurs and causes detrimental effects including embry-
onic lethality, lack of T cell proliferation, and intestinal and skin
inflammation (Bonnet et al., 2011; Ch’en et al., 2011; Osborn
et al., 2010; Welz et al., 2011; Zhang et al., 2011).
Given the critical role of death in regulating DC functions and
its subsequent effect in directing immune responses, we sought
to examine the function of FADD in DCs. Using DC-specific con-
ditional knockout mice, we found that FADD was essential in
limiting DC necroptosis. In the knockout mice, DC numbers
were decreased, especially in gut-associated populations, due
to uncontrolled DC death. Importantly, the dysregulation of DC
death resulted in the appearance of chronic systemic inflamma-
tion characterized by increased levels of serum TNF and an
expansion in myeloid and B cells. We further identified a critical
role for the intestinal microbiota in the development of inflamma-
tory responses to necroptotic DCs that required MyD88-depen-
dent signals in non-DC cells. Our study uncovers an essential
connection between the commensal microbiota and necropto-
sis-induced inflammation.
RESULTS
Decreased Dendritic Cell Numbers in Gut-Associated
Lymphoid Tissues
To better understand the role of FADD in DC homeostasis and
effector functions, we generated conditional knockout mice by
crossing CD11c-Cre transgenic mice to mice containing floxed
alleles of FADD (Caton et al., 2007; Osborn et al., 2010). These
mice (termed dcFADD/) exhibited a specific loss of FADD
protein expression in CD11c+-enriched splenocytes and in-vitro-
generated bone-marrow-derived dendritic cell (BMDC) by west-
ern blot analysis (Figure 1A). Previous studies have shown that
DCs accumulate in the absence of apoptosis, and this subse-
quently leads to increased lymphocyte activation and autoim-
mune disease development (Chen et al., 2006; Mabrouk et al.,
2008; Stranges et al., 2007). We therefore assessed the DC pop-
ulations by first examining cell numbers. Unexpectedly, the loss
of FADD did not lead to DC accumulation. Instead, a small but
significant decrease in the number of CD11chiMHCII+ conven-
tional DCs (cDCs) was detected in the spleen of dcFADD/
mice compared to littermate control mice (Figure 1B), whereas
the number of plasmacytoid dendritic cells (pDC, CD11clo
Siglec-H+B220+) in bone marrow was unchanged (Figure 1B).
This result is consistent with the restricted expression of Cre re-
combinase byCD11c-Cre to the cDCbut not the pDC population
(Birnberg et al., 2008). We further investigated different subsets
of splenic cDCs by examining CD8 and Sirp1a expression.
Compared to other DC subsets, the CD8+Sirp1a DC subset
has been identified to efficiently cross-present antigens to
CD8+ T cells (Shortman and Heath, 2010). In these dcFADD/
mice, the percentage of CD8+Sirp1a DCs was diminished,
whereas the CD8Sirp1a+ subset was increased (Figure 1C).
Because only a modest decrease in the cDC population was
detected in the spleen, we investigated changes in DC numbers
in other peripheral lymphoid organs, in particular, the gut-asso-
ciated lymphoid tissues (GALTs). The mesenteric lymph nodes
(MLNs), and Peyer’s patches were examined for CD103+ migra-
tory DCs (Coombes and Powrie, 2008; Scott et al., 2011). Inter-
estingly, we observed a dramatic reduction of CD103+ DCs in the
GALT of dcFADD/ mice compared to the spleen, suggesting
that the intestinal microbiota might stimulate DC death (Fig-
ure 1D). We subsequently measured the levels of Flt-3L in the
serum, because Flt-3L levels have been shown to increase in
mice deficient of DCs (Birnberg et al., 2008). We found that Flt-
3L was indeed slightly elevated in the sera of dcFADD/ mice
compared to littermate controls (Figure 1E).
The importance of FADD in DC functions was also determined.
DCs isolated from theMLNs expressed equivalent levels of MHC
and costimulatory molecules (Figure S1). Following stimulation
with lipopolysaccharide (LPS), FADD-deficient BMDCs were
capable of inducing TNF and IL-12 similar to that of controlCBMDCs (Figure 1F). Additionally, the ability to stimulate anti-
gen-specific responses by FADD-deficient DCs was evaluated.
Proliferation of ovalbumin-specific CD8 T cells (OT-I T cells) in
response to ovalbumin peptide (SIINFEKL)-pulsed BMDC was
induced in vitro or in vivo. Both control and FADD-deficient
BMDCs stimulated OT-I cell proliferation in vitro and in vivo (Fig-
ures 1G and 1H). Taking these data together, the deletion of
FADD in DCs does not impair their ability to produce cytokines
or to initiate T cell responses. However, dcFADD/mice exhibit
a striking decrease in the number of gut-associated DCs.
Systemic Inflammation in dcFADD/ Mice Results in
Splenomegaly and Lymphadenopathy
The dcFADD/ mice at first appeared healthy with no obvious
abnormalities. However, by 4–8 weeks of age, these mice ex-
hibited splenomegaly and lymphadenopathy compared to litter-
mate controls (Figures 2A and 2B). Increased numbers of
Ter119+ erythrocytes contributed to the enlargement of the
spleens (Figure 2C). In contrast, erythroid cell numbers in the
bone marrow of dcFADD/ mice were lowered compared to
their littermate controls (Figure 2C). We also detected elevated
B cell numbers in the spleen and lymph nodes of dcFADD/
mice (Figure 2D; data not shown). However, the absolute
numbers of CD3+ T cells and the proportion of CD4 and CD8
T cells were similar between littermate controls and dcFADD/
mice (Figure 2D; data not shown). Strikingly, numerous myeloid
cell populations were increased in the spleens of dcFADD/
mice compared to control mice (Figures 2E–2G). Flow cytomet-
ric analysis of splenocytes revealed elevated numbers of in-
flammatory monocytes (Ly6ChiCD11b+) in dcFADD/ mice
compared to control littermates (Figures 2E and 2F). In addition,
the neutrophil population (Ly6CloLy6G+CD11b+) in the spleen
and blood was also increased (Figures 2E, 2F, and S2A). The
numbers of F4/80+CD11b+ macrophages were also elevated in
dcFADD/ mice compared to control mice (Figure 2G).
Increased numbers of inflammatory monocytes, neutrophils,
and macrophages were also detected in the lymph nodes
(data not shown). These data reveal that the dcFADD/ mice
display signs of systemic inflammation.
To further assess inflammation in the dcFADD/ mice, we
measured the levels of different proinflammatory cytokines in
the serum. A significant increase in basal TNF, interferon (IFN)-
g, andMCP-1 amounts was detected in the serumof dcFADD/
mice compared to control mice (Figure 2H). In contrast, serum
levels of IL-1bwere undetectable in both dcFADD/ and control
mice (data not shown). To determine the ramifications of having
increased inflammation, control or dcFADD/ mice were given
a low dose of LPS (100 mg) without the sensitizing agent D-galac-
tosamine. Under this condition, most wild-type mice survived
(Figure 2I). However, dcFADD/ mice were unable to recover
and died of LPS-induced endotoxic shockwithin 18 hr (Figure 2I).
The levels of proinflammatory cytokine TNF were significantly
increased in the sera of dcFADD/ mice following the injection
of LPS (Figure 2J, 40–60 ng/ml). Elevated IL-1b was also de-
tected (Figure S2B) but at lower levels (<1 ng/ml). These results
indicate that LPS-stimulated death of dcFADD/ mice is
caused by the lethal effects of elevated proinflammatory cyto-
kines or by TNF-induced lethal systemic inflammation responseell Reports 3, 1932–1944, June 27, 2013 ª2013 The Authors 1933
Figure 1. Lower cDC Numbers in dcFADD/ Mice
(A) FADD protein expression was assessed in CD11c+-enriched splenocytes and BMDCs by western blotting (Ctl, control).
(B) Absolute cell numbers of conventional DCs (cDC: CD11chi) from the spleen and plasmacytoid DCs (pDC: CD11cloB220+Siglec H+) from the bonemarrowwere
plotted.
(C) Splenic cDC (CD11chiMHC II+) subsets were distinguished by CD8 and Sirp1a expression.
(D) Intestinal CD103+ DCs in the mesenteric lymph nodes (MLNs) and Peyer’s patches were isolated, and cell numbers were calculated.
(E) Flt-3L amounts in the serum were measured by ELISA.
(F) Control (dashed) or dcFADD/ (solid) BMDCswere stimulatedwith 10 ng/ml LPS for 6 hr, and intracellular TNF or IL-12 were examined. Histogram plots show
cytokine production in CD11c+CD11b+ BMDCs. Shaded, unstimulated; dashed, control; solid, dcFADD/.
(G) CFSE-labeled OT-I cells were cultured with SIINFEKL-pulsed BMDCs (shaded, control; solid line, dcFADD/) for 72 hr, and OT-I T cell proliferation was
measured.
(H) CFSE-labeled OT-I cells were adoptively transferred into b2 m/mice, and SIINFEKL-pulsed BMDCs (shaded, control; solid line, dcFADD/) were injected
into the footpad 24 hr later. Seventy-two hours after BMDC injections, the draining popliteal lymph nodes were harvested to examine T cell proliferation. His-
tograms are representative of duplicate samples and two separate experiments (G and H).
Data are representative of at least three independent experiments (A–F). Plots show mean ± SEM, and each point represents an individual animal (B, D, and E).
See also Figure S1.
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Figure 2. dcFADD/ Mice Exhibit Systemic
Inflammation and Increased Sensitivity to
LPS Endotoxic Shock
(A and B) Weights of spleens (A), peripheral (PLN),
or mesenteric (MLN) lymph nodes (B) from Ctl or
dcFADD/ mice.
(C) Numbers of Ter119+ erythroid in the spleen or
bone marrow of Ctl (white bars) or dcFADD/
(hatched bars) mice (n = 10 for bone marrow, n = 8
for spleen).
(D) CD3 and B220 staining to examine splenic B
and T lymphocyte populations. Numbers represent
total cell numbers and cell percentages. Data are
representative of five separate experiments.
(E) Flow cytometric analysis of inflammatory
monocyte (IM: Ly6ChiCD11b+) and neutrophil (Nf:
Ly6CloLy6G+CD11b+) populations in the spleen.
Plots are representative of more than five inde-
pendent experiments.
(F and G) Numbers of IM (F, upper panel), Nf (F,
lower panel), and macrophages (G, Mf:
F4/80+CD11b+) in the spleen.
(H) Serum cytokine levels (pg/ml) were measured
by flow cytometry using cytometric bead array
(CBA) (n = 7).
(I) Ctl (circles, n = 11) or dcFADD/ (triangles, n =
13) mice were injected with 100 mg of LPS i.p., and
survival was compared.
(J) One hour after LPS injections, the amounts of
serum cytokines (ng/ml) were measured by CBA.
Bar graph and scatterplots represents mean ±
SEM. Each point represents an individual animal
and pooled from multiple analyses (A, B, F–H, and
J). See also Figure S2.syndrome (Duprez et al., 2011). Although there are some similar-
ities to mice that completely lack cDCs (Birnberg et al., 2008;
Ohnmacht et al., 2009), the dcFADD/ mice exhibit numerous
unique phenotypes. Our data specifically demonstrate that
dcFADD/ mice develop systemic inflammation characterized
by elevated levels of proinflammatory cytokines and increasedCell Reports 3, 1932–194numbers of inflammatory monocyte, neu-
trophils, macrophages, and B cells. As a
consequence, this increased inflamma-
tion enhances sensitivity to LPS-induced
endotoxic shock.
RIP3-Dependent Necroptosis Is
Responsible for DC Death and
Systemic Inflammation
We next determined the reason for the
reduction in DC numbers, and whether
the decrease in DCs was responsible
for the systemic inflammation observed
in the dcFADD/ mice. Necroptosis has
been described to occur in the absence
of apoptosis and requires the kinase ac-
tivities of RIP1 and RIP3 (Cho et al.,
2009; He et al., 2009; Sun et al., 1999).
We hypothesized that the lowered DC
numbers in dcFADD/ mice was the
result of FADD-deficient DCs dying by necroptosis. Therefore,
we first assessed the ability of FADD-deficient DCs to undergo
necroptosis in response to Toll-like receptor (TLR) stimulation.
BMDCs generated from dcFADD/ or control mice were stimu-
lated with LPS, and cell death was examined by labeling cells
with Annexin V and 7AAD. LPS stimulation induced necroptotic4, June 27, 2013 ª2013 The Authors 1935
(legend on next page)
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cell death (7AAD+/Annexin V) in FADD-deficient DCs that was
not detected in control cells (Figure 3A). Addition of zVAD, a
pan-caspase inhibitor, in combinationwith LPS further increased
cell death in both wild-type and FADD-deficient DCs (Figure 3A).
Because zVADblocks apoptosis by inhibiting caspase-8 activity,
this result suggested the presence of an alternative caspase-
dependent but FADD-independent pathway to death. Interest-
ingly, LPS-induced cell death was only partially rescued by the
RIP1 kinase inhibitor Nec-1, implying that LPS stimulated
some cells to die by a RIP1-independent manner (Figure 3A).
Necrotic cell death was reported to induce IL-1 release and to
promote inflammation (Rock et al., 2010). Following LPS stimu-
lation, increased death of dcFADD/ cells corresponded with
elevated levels of mature IL-1b, whereas the induction of TNF
was similar between FADD-deficient and control cells (Figures
S3A–S3C). Inflammatory contents released by necrotic cells
can trigger potassium efflux, resulting in NLRP3 inflammasome
activation and IL-1 processing (Pe´trilli et al., 2007). Inhibition of
potassium efflux from cells prevented IL-1b production in
dcFADD/ DCs without altering the amount of cell death (Fig-
ure S3D and S3E). These data demonstrate that LPS-stimulated
dcFADD/ DCs can undergo necroptosis in vitro and release
processed IL-1b.
To further assess necroptosis in DCs, we crossed dcFADD/
mice to RIP3/ mice to generate dcFADD/RIP3/ double-
knockout (DKO) mice. BMDCs were generated from
dcFADD/RIP3/ mice, and necroptosis was measured
following LPS stimulation. As mentioned above, LPS-stimulated
death of FADD-deficient DCs was only partially rescued by Nec-
1 (Figures 3A and 3B). However, the deletion of RIP3 completely
rescued LPS-induced death (Figure 3B). These data demon-
strate that in the absence of FADD, DCs can undergo RIP1-
dependent and -independent necroptosis, both of which are
dependent on RIP3. In contrast, DC death following TNF treat-
ment was completely rescued by Nec-1, suggesting that pro-
grammed necrosis induced by TNF is dependent on both RIP1
and RIP3 (Figure S4A).
We subsequently investigated the role of RIP3-dependent
necroptosis in the development of systemic inflammation in
dcFADD/ mice. Strikingly, much of the inflammatory pheno-
types detected in the dcFADD/ mice were abrogated in the
dcFADD/RIP3/ mice. The significant increase in spleen
weight seen in dcFADD/ mice was no longer observed in
dcFADD/RIP3/ DKO mice, nor was there a difference inFigure 3. RIP3 Deletion Prevents DC Necroptosis and Systemic Inflam
(A) Control (Ctl, upper panels) and dcFADD/ (lower panels) BMDCs were pretre
10 ng/ml LPS for 16 hr. Cells were labeled with Annexin V and 7AAD. Data are re
(B) Ctl (white bars), dcFADD/ (gray bars), dcFADD/RIP3/ (diagonal bars
measured as in (A) (US, unstimulated). Bar graph shows mean percentage of dea
individual experiments.
(C) Spleen weights from Ctl, dcFADD/, dcFADD/RIP3/, or RIP3/ mice.
(D) Ter119+ erythroid cells in the spleen and bone marrow (Ctl, white bars, n = 5
RIP3/ (hatched bars, n = 4).
(E and F) Number of inflammatory monocyte (IM) and macrophage (Mf) in the sp
(G) DC subsets in the spleen were assessed by gating on CD11chiMHCII+ cDCs a
plots are representative of three independent experiments.
Scatterplots represents mean ± SEM (n.s., not significant). Each point represents
S3 and S4.
Cthe erythrocyte populations (Figures 3C and 3D). Furthermore,
the increased numbers of inflammatory monocytes, neutrophils,
and macrophages observed in the dcFADD/ mice were not
detected in dcFADD/RIP3/ DKO mice (Figures 3E and
S4B). Although a slight increase in these myeloid populations
was detected in the dcFADD/RIP3/ DKO mice compared
to RIP3/ mice, no statistical differences were detected
between DKO mice and control mice (Figures 3E and S4B).
Normal numbers of myeloid cell populations correlated with
decreased levels of inflammatory cytokines in the sera of
dcFADD/RIP3/ DKO mice (Figure S4C; data not shown).
Because the deletion of RIP3 in FADD-deficient cells pre-
vented necroptotic death in vitro (Figure 3B), we expected that
DC numbers would be rescued in dcFADD/RIP3/ mice. As
shown in Figure 3F, similar numbers of CD103+ migratory DCs
were detected in theMLNs of dcFADD/RIP3/DKO and con-
trol mice (Figure 3F). Thus, RIP3 deletion prevented FADD-defi-
cientCD103+DCs fromdying. The deletion ofRIP3 in dcFADD/
mice also rescued the proportions of CD8+ and Sirp1a+ DC sub-
sets (Figure 3G). Consequently, Flt-3L levels in the serum of
dcFADD/RIP3/ DKO mice were similar to control and
RIP3/mice (Figure S4D). Furthermore, expression of costimu-
latory molecules was not affected by the absence of RIP3 (Fig-
ure S4E). Together, these results indicate an obligatory role for
RIP3 in dcFADD/ DC death, and this RIP3-dependent death
stimulates the development of systemic inflammation in vivo.
MyD88-Dependent Signaling in DCs and Non-DCs Is
Crucial for Inflammation in dcFADD/ Mice
In the absence of FADD, DCs died by necroptosis when stimu-
lated with LPS or other TLR ligands as shown above. Therefore,
we hypothesized that reduced DC numbers in the GALT of
dcFADD/ mice could be a consequence of necroptosis
induced by TLR ligands presented by commensal microflora.
Necroptotic DC death may then release DAMPs (Danger Associ-
ated Molecular Patterns proteins) capable of activating other
innate cells, resulting in inflammation (Kono and Rock, 2008).
MyD88 is an adaptor molecule for IL-1R and most TLRs (Barton
and Medzhitov, 2003; Beutler and Rietschel, 2003). To assess
the role MyD88 plays in the dcFADD/ phenotype, we crossed
dcFADD/ mice to MyD88flox/flox mice to generate
dcFADD/dcMyD88/ mice, which specifically deleted both
FADD andMyD88 in the DC population. When we examined the
dcFADD/dcMyD88/ mice for inflammation, an increase inmation
ated with either 10 mM zVAD, 30 mMNec-1, or DMSO and then stimulated with
presentative of at least five experiments.
), and RIP3/ (hatched bars) BMDCs were stimulated, and cell death was
th ± SEM (percentage 7AAD+/Annexin V) and representative of at least three
); dcFADD/ (gray bars, n = 3); dcFADD/RIP3/ (diagonal bars, n = 5); or
leen (E) and CD103+ DCs in the MLN (F).
nd examining CD8 and Sirp1a expression. Numbers are cell percentages, and
an individual animal and pooled from multiple analyses (C–F). See also Figures
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Figure 4. Deletion of MyD88 in DCs Does Not Prevent Death but Partially Rescues dcFADD/ Phenotypes
(A) Spleen weights from control (Ctl), dcFADD/, dcFADD/dcMyD88/, or dcMyD88/ mice.
(B and C) Numbers of inflammatory monocytes, neutrophils (B, IM and Nf), and macrophages (C) in the spleen.
(D) CD103+ DC numbers in the MLN.
(E) BMDCs generated from control (white bars), dcFADD/ (gray bars), dcFADD/dcMyD88/ (diagonal bars), and dcMyD88/ (hatched bars) mice were
pretreated with 30 mM Nec-1, or DMSO and then stimulated with 10 ng/ml LPS for 16 hr and labeled with Annexin V and 7AAD to measure cell death (US,
unstimulated).
Bar graphs plotted as mean percentage of death ± SEM and are representative of three individual experiments. Scatterplots represents mean ± SEM (n.s., not
significant). Each point represents an individual animal and pooled from multiple analyses (A–D). See also Figure S5.the spleenweightswas still observed (Figure 4A). However, a par-
tial rescue in the numbers of inflammatory monocytes,
neutrophils, and macrophages was detected, suggesting
a reduction in the levels of inflammation (Figures 4B
and 4C). These myeloid populations were reduced in
dcFADD/dcMyD88/ mice compared to dcFADD/ mice
but slightly increased when compared to control or dcMyD88/
mice (Figures 4B and 4C). When the CD103+ DC population was
examined, cell numbers were significantly decreased in
dcFADD/dcMyD88/ mice compared to control or
dcMyD88/ mice (Figure 4D). Despite the dramatic reduction
of DCs in the MLNs, cells deficient of FADD and MyD88 were
capable of upregulating MHC and costimulatory molecules (Fig-
ure S5). LPS stimulation of FADD- and MyD88-double-deficient
BMDCs still induced death when compared to MyD88-deficient
cells, although the percentage of death was slightly lower than
in FADD-deficient cells (Figure 4E). These results suggest that
MyD88-dependent signaling has a role in the initiation of necrop-
totic death in FADD-deficient DCs in vitro but is not essential
in vivo. Commensal bacteriamay still stimulate DC death through
the TLR4 adaptor molecule TRIF, which has been previously
shown to interactwithRIP3 to initiate necroptosis (Heet al., 2011).1938 Cell Reports 3, 1932–1944, June 27, 2013 ª2013 The AuthorsBecause we observed a partial rescue of the systemic inflam-
mation in dcFADD/dcMyD88/ mice, we investigated
whether MyD88 signaling was necessary in other cells types.
Interactions between commensal bacteria and host cells rely
on MyD88-dependent signals to elicit innate immune responses
and to maintain intestinal homeostasis (Hooper et al., 2012).
Therefore, to further examine the importance of MyD88 in
the development of inflammation, we crossed dcFADD/
mice to complete MyD88/ knockout mice to generate
dcFADD/MyD88/ DKO mice. In these mice, MyD88 was
deleted from all cell populations. These mice revealed a dramat-
ically marked decrease in spleen size and weight, such that
organ weights were similar to control mice (Figure 5A). Further-
more, the erythrocyte population in the spleen was reduced to
wild-type numbers in the dcFADD/MyD88/ DKO mice
when compared to dcFADD/ mice (Figure 5B). The B cell
population in the DKO mice was also reduced and resembled
the numbers observed in MyD88/ controls (Figure 5C). Addi-
tionally, the myeloid cell populations (inflammatory monocytes,
neutrophils, and macrophages) in the dcFADD/MyD88/
mice also returned to similar cell numbers as control mice (Fig-
ure 5D). Accordingly, the elevated levels of TNF in dcFADD/
Figure 5. MyD88-Dependent Signaling Is Required for the Development of Inflammation in dcFADD/ Mice
(A) Weights of spleens from control (Ctl), dcFADD/, dcFADD/MyD88/, or MyD88/ mice.
(B) Ter119+ erythroid cells in the spleen and bone marrow (Ctl, white bars, n = 5); dcFADD/ (gray bars, n = 3); dcFADD/MyD88/ (diagonal bars, n = 5);
MyD88/ (hatched bars, n = 4).
(C and D) Absolute numbers of B220+ B cell (C), inflammatory monocyte, neutrophil, and macrophage (D, IM, Nf, and Mf, respectively) in the spleen.
(E) TNF levels (pg/ml) in the serum were measured by ELISA.
(F) Splenic DCs (CD11chiMHC II+) numbers were measured and plotted.
(G) The levels of serum Flt-3L were measured by ELISA.
Scatterplots represents mean ± SEM (n.s., not significant). Each point represents an individual animal pooled from multiple analyses (A and C–G).mice were lowered to wild-type amounts in dcFADD/
MyD88/ mice (Figure 5E). Similar to results with
dcFADD/dcMyD88/ mice, complete deletion of MyD88
did not rescue DC numbers (Figure 5F). The DCs in
dcFADD/MyD88/ DKO mice were significantly decreased
compared to the numbers of DCs detected in control and
MyD88/ mice (Figure 5F). The diminished DC numbers in
dcFADD/MyD88/ DKO mice also correlated with elevatedCFlt-3L amounts (Figure 5G). These results demonstrate that
MyD88 is not necessary for the reduction in the cDC population.
In the absence of MyD88, DCs still die by necroptosis.
However, MyD88 is required for the development of inflamma-
tion observed in dcFADD/ mice. Thus, MyD88-dependent
signaling in populations other than DCs is surprisingly crucial
for the development of systemic inflammation in response to
DC necroptosis.ell Reports 3, 1932–1944, June 27, 2013 ª2013 The Authors 1939
Systemic Inflammation in dcFADD/Mice Is Abrogated
by Antibiotic Treatment
A potential explanation for the requirement of MyD88 in the
development of inflammation is that the commensal microflora
signals through MyD88-dependent pathways, which ‘‘primes’’
cells for DAMP-induced inflammation. The appreciable
decrease of CD103+migratory DCs in theGALT and the absence
of systemic inflammation in dcFADD/MyD88/ mice sup-
ported a role for commensal bacteria (Figures 1D and 5). To elim-
inate most of the commensal microflora, we treated 2-day-old
mice with a broad spectrum of antibiotics for 4–5 weeks.
Following antibiotic treatment, dcFADD/ and control mice
had similar-sized spleens and MLNs (Figure 6A). Furthermore,
antibiotic treatment reduced the number of inflammatory mono-
cytes, neutrophils, macrophages, and B cells in dcFADD/
mice (Figures 6B and 6C). Therefore, the systemic inflammation
observed in untreated dcFADD/ mice was rescued in antibi-
otic-treated animals. In support of the MyD88 data, results
from the antibiotic treatments validate the contribution of intesti-
nal microbiota to the systemic inflammation in dcFADD/mice.
Thus, the signals generated from necroptotic DCs alone are
insufficient to trigger the development of inflammation.
DISCUSSION
The analysis of mice with FADD-deficient DCs has allowed us to
investigate the importance of FADD in dendritic cell death, the
effect of necroptotic death on the immune response, and the
role of commensal bacteria on different immune cell populations.
FADD deficiency sensitized cells to necrotic death leading to
decreased DCs in mice. In contrast to FADD-deficient T cells
that are nonfunctional (Osborn et al., 2010; Zhang et al., 2011),
FADD-deficient DCs were able to secrete cytokines and induced
antigen-specific T cell responses. Additionally, dcFADD/mice
had a heightened state of systemic inflammation, which was
different from other tissue-specific FADD-deficient mice that ex-
hibited localized inflammation (Bonnet et al., 2011; Welz et al.,
2011). It is surprising that death of a proportion of dendritic cells
in the GALT was capable of driving system-wide effects. Dele-
tion of RIP3 in dcFADD/ mice rescued DC death and also
decreased systemic inflammation to normal levels, suggesting
DC necroptosis is responsible for all the dcFADD/ mouse
phenotype. However, without assessing DC-specific RIP3-defi-
cient mice, we cannot exclude the formal possibility of RIP3
deletion in other cell types playing a role as well. Blocking signals
from commensal microbiota with MyD88 deficiency in all
cell populations also abrogated systemic inflammation in
dcFADD/ mice. These experiments describe not only a role
for FADD in preventing necroptosis in DCs, but also demonstrate
a role for commensal bacteria in an inflammatory response
against necroptotic cells, which presumably release inflamma-
tion-inducing molecules.
Necroptosis is a form of cell death initially described to be
downstream of the death receptors requiring RIP1 and RIP3
interaction and their kinase activities (Cho et al., 2009; He
et al., 2009). FADD-deficient DCs were more sensitive to cell
death in response to TLR stimulation in vitro. In vivo, FADD-defi-
cient DCs presumably died from stimulation by commensal1940 Cell Reports 3, 1932–1944, June 27, 2013 ª2013 The Authorsmicroflora. We found that LPS-induced death of dcFADD/
cells was only partially inhibited by Nec-1 but completely
blocked in the absence of RIP3. Conversely, TNF-stimulated
death was completely rescued by Nec-1 treatment. These data
suggest that TLR4 can induce both a RIP1/RIP3-dependent
death and a RIP3-dependent but RIP1-independent death. The
RIP1/RIP3-dependent death can potentially be mediated by up-
regulation of TNF by TLR signaling, in turn signaling through the
TNF-RI to induce RIP1-dependent necroptosis. RIP1-indepen-
dent and RIP3-dependent death may be initiated directly down-
stream of TLR4 as previously described by other groups (He
et al., 2011; Upton et al., 2010, 2012). In FADD-deficient DCs,
RIP3-dependent necroptosis is likely linked to the adaptor pro-
tein TRIF downstream of TLR4. TRIF is a known adaptor protein
that can associate with TLR4 or TLR3, receptors for LPS and
poly(I:C), respectively (Yamamoto et al., 2002). Indeed,
dcFADD/dcMyD88/ BMDCs still died when stimulated
with LPS. In this case, FADD may serve as a negative inhibitor
of the TRIF-RIP3 complex.
The absence of FADD in other cell types also caused marked
sensitivity to necroptosis (Bonnet et al., 2011; Osborn et al.,
2010; Welz et al., 2011; Zhang et al., 2011). Similarly, caspase-
8 deficiency exhibited the same sensitivity to RIP3-dependent
programmed necrosis (Ch’en et al., 2011; Gu¨nther et al., 2011;
Kaiser et al., 2011; Oberst et al., 2011). Interestingly, during the
writing of this manuscript, a report showed that LPS alone did
not stimulate necroptotic death in caspase-8-deficient DCs
(Casp8) (Kang et al., 2013). This is in contrast to FADD-deficient
DCs, which exhibit exacerbated death upon LPS stimulation. In
addition, ATP release from dying cells likely stimulates IL-1b
production by dcFADD/ cells. Potassium treatment dimin-
ished IL-1b levels, implying a role for potassium efflux and the
NLRP3 inflammasome (Pe´trilli et al., 2007). In addition, there
are unique phenotypes in the dcFADD/ mice not observed in
Casp8 mice. For instance, fewer DC numbers were observed
in dcFADD/ mice, whereas Casp8 mice exhibited unaltered
or increased DC numbers. Increased macrophage and B cell
populations with augmented TNF levels were observed in
dcFADD/ but not Casp8 mice. The difference in necroptosis
execution in FADD and caspase-8 DCmodels highlights the crit-
ical role FADD plays in cell death. Caspase-8/RIP3 DKO mice
suffered from T and B cell autoimmunity at an early age, marked
by an increase of the signature CD3+B220+ population and
elevated levels of ANA. Preliminary results indicate that
6-week-old dcFADD/RIP3/ mice also exhibited elevated
number of CD3+B220+ double-positive cells, but no antinuclear
antibodies were detected (data not shown). It remains to be
seen whether aged dcFADD/RIP3/ will have an accumula-
tion of cDCs and develop systemic autoimmunity.
Some phenotypes in dcFADD/ mice, including the expan-
sion of monocytes, neutrophils, and erythrocytes in the spleen,
as well as decreased red blood cells in the bone marrow, were
similar to what was observed in mice lacking cDCs, also known
as DC-less mice (Birnberg et al., 2008; Ohnmacht et al., 2009).
Flt-3L had been shown to control homeostasis of DCs in the
bone marrow and periphery (Hochweller et al., 2009; McKenna
et al., 2000) andwas thought to be themain culprit for the pheno-
type of DC-less mice. The receptor kinase Flt-3 is critical in DC
Figure 6. Treatment with Broad-Spectrum Antibiotics Rescues Systemic Inflammation in dcFADD/ Mice
Mice were treated with a cocktail of antibiotics in the drinking water from day 2 of birth until the time of analysis (at 4–5 weeks of age).
(A) Spleen (upper panels) and MLN (lower panels) weights from nontreated (no treatment, left panels) and antibiotic-treated (right panels) mice were measured.
(B) Absolute numbers of inflammatory monocytes (IM), neutrophils (Nf), and macrophages (Mf) in the spleen.
(C) B220+ and CD3+ lymphocyte populations in the spleen of nontreated (upper panels) or antibiotic-treated (lower panels) mice were analyzed (Ctl mice, left
panels; dcFADD/ mice, right panels).
Numbers represent total cell numbers and cell percentages. Scatterplots represents mean ± SEM, and each point represents an individual animal (n.s., not
significant). Data are representative of three separate experiments (A–C).development and is expressed on common myeloid progenitors
and differentiated DCs (Karsunky et al., 2003; Waskow et al.,
2008). In previous reports on DC-less mice, the increased Flt-
3L levels compensating for the changes in cell homeostasis led
to myeloproliferative disease and erythrocyte imbalance (Birn-Cberg et al., 2008). The decreased DC numbers in the spleen
and GALT were sufficient to induce a moderate increase in Flt-
3L. The ability of Flt-3L to expand the progenitor population al-
lows for the repopulation of DCs in the periphery (Hochweller
et al., 2009; Karsunky et al., 2003; Waskow et al., 2008). Thus,ell Reports 3, 1932–1944, June 27, 2013 ª2013 The Authors 1941
elevated serum levels of Flt-3L in dcFADD/ mice may contin-
ually differentiate progenitor cells into DCs, thereby dampening
the reduction in splenic cDC numbers. However, in contrast to
DC-less mice, dcFADD/ mice also exhibited elevated levels
of TNF and other cytokines as well as higher numbers of macro-
phages and B cells. Increased Flt-3L in the serum is not likely to
be the main reason for increased myeloid and erythrocyte pop-
ulations in dcFADD/ mice. Consistent with this, serum levels
of Flt-3L were elevated in dcFADD/MyD88/mice, but the in-
flammatory phenotype of dcFADD/ mice were not exhibited.
The role of MyD88-dependent signals in the induction of
inflammation was examined by crossing dcFADD/ mice with
MyD88/mice. The absence ofMyD88 did not rescue the death
of DCs in dcFADD/ mice. However, the inflammatory pheno-
type in dcFADD/ mice was completely absent in
dcFADD/MyD88/mice. On the other hand, specific deletion
ofMyD88 in the DC population only partially rescued the pheno-
type exhibited by dcFADD/ mice. In this case, TLR signaling
was defective in only a small proportion of cells, whereas
MyD88-dependent signals remained intact in other cell popula-
tions. Although MyD88-dependent signals were not necessary
for DC death, these data suggested that signaling through
MyD88 was required for most of the inflammatory phenotypes
observed in dcFADD/ mice. MyD88 is an essential adaptor
for signaling through TLRs and IL-1/18 receptors (Barton and
Medzhitov, 2003; Beutler and Rietschel, 2003). In previous re-
ports, IL-1 signaling was responsible for the inflammation
induced by necrotic cells, thus MyD88/ mice failed to recruit
neutrophils in response to dead cells (Rock et al., 2010). Stimu-
lation of FADD-deficient cells produced increased amounts of IL-
1b in vitro, which implies that IL-1b could contribute to the
inflammation detected in dcFADD/ mice. However, the levels
of IL-1bwere undetectable in dcFADD/mice. Therefore, IL-1b
does not appear to play a significant role in the inflammation in
dcFADD/ mice, and the absence of inflammatory responses
in the dcFADD/MyD88/ mice is the outcome of defective
TLR signaling.
TLR ligands from commensal microflora are likely the source
of ‘‘tonic signals’’ which prime cells to respond to DAMPs. Closer
examination of themigratory DCs from the gut revealed a greater
decrease in this DC subset, suggesting a role for intestinal micro-
biota. Administration of broad-spectrum antibiotics rescued the
inflammatory phenotypes in dcFADD/ mice. These data sup-
ported a role forMyD88-dependent signaling in the development
of inflammation. Intestinal DCs constantly survey the gut micro-
biota in order to maintain intestinal homeostasis. At the same
time, the intestinal microflora can influence immune responses
by stimulating MyD88 signaling pathways in various cell popula-
tions (Hooper et al., 2012). For example, productive antiviral im-
mune responses have been reported to depend on the presence
of commensal bacteria (Abt et al., 2012; Ichinohe et al., 2011).
One explanation for needing intestinal microflora in immunity is
that gut commensals provide signals to prime immune cells for
activation, and indeed macrophages isolated from antibiotic-
treated mice are less responsive to viral stimulation (Abt et al.,
2012). Therefore, a potential model for the dcFADD/ mice
may be that commensal microbiota provide MyD88-dependent
signals that prime myeloid and B cells to respond to inflamma-1942 Cell Reports 3, 1932–1944, June 27, 2013 ª2013 The Authorstory stimuli. Activation of primed myeloid/B cells by necroptotic
FADD-deficient DCs then elicits an inflammatory response. In
the absence of commensal-generated signals, either by antibi-
otic treatment or by MyD88 deletion, stimulation from necrop-
totic DCs alone is not sufficient to induce inflammation. Thus,
our studies uncover a critical relationship between commensal
microbiota and the ability of innate immune cells and B cells to
respond to necroptotic cells. In addition, we found that dysregu-
lation of DC necroptosis at intestinal sites can drive systemic
inflammation. More importantly, these data demonstrate that
commensal microbiota are necessary for a functional immune




Mice were used at 6–12 weeks of age unless otherwise noted. Littermates or
sex- and age-matched (within 10 days) mice were used as controls.
dcFADD/ mice were generated by crossing CD11c-Cre transgenic mice
with FADDflox mice. Mice containing FADD alleles floxed with loxP sites were
generated in the lab and backcrossed to C57BL/6 for at least ten generations
(Osborn et al., 2010). CD11c-Cremice have been previously described (Caton
et al., 2007). MyD88/ mice (in C57BL/6 background) were provided by Dr.
Shizuo Akira (Adachi et al., 1998) through Dr. Greg Barton, and RIP3/
mice (backcrossed to C57BL/6 for more than eight generations) were from
Dr. Xiaodong Wang (He et al., 2009). MyD88flox mice (Hou et al., 2008) were
purchased from The Jackson Laboratory. For antibiotic treatment, mice
were fed a cocktail of 1 mg/ml ampicillin, 1 mg/ml neomycin, 0.5 mg/ml cipro-
floxacin, and 0.5 mg/ml meropenem in the drinking water flavored with
20 mg/ml grape Kool-Aid from day 2 of birth. Following weaning, mice main-
tained on the same antibiotic cocktail except with 0.5 mg/ml vancomycin in
place of ciprofloxacin until analysis (Welz et al., 2011). Mice treated with anti-
biotics were analyzed between 4 and 5 weeks of age. All experiments utilized
cohoused mice. Experimental mice were housed in the animal facility at the
University of California, Berkeley, and all procedures involving animals were
approved by the Animal Care and Use Committee.
Dendritic Cell Enrichment
To isolate splenic DCs, spleens were cut into small pieces, digested with colla-
genase IV (GIBCO) at 37C for 35 min, and then incubated with 25 mM EDTA
for 5 min at room temperature before dissociating and filtering cells through a
100 mm strainer. CD11c+ DCs were enriched using CD11c magnetic particles
(Miltenyi Biotec) according to manufacturer’s instructions.
Bone marrow was flushed from femurs and tibias using a needle and
syringe. Red blood cells were lysed, and 2 3 106 BM cells were cultured
in 10 cm non-tissue-culture-treated dishes in complete RPMI-1640 sup-
plemented with 10% FCS, L-glutamine, penicillin-streptomycin, sodium
pyruvate, 2-mercaptoethanol, and granulocyte macrophage colony-stimu-
lating factor (GMCSF) (collected supernatant from X63-GMCSF cell line (Zal
et al., 1994), a generous gift of Dr. Brigitta Stockinger at National Institute for
Medical Research, London through Dr. Tomasc Zal at Scripps). Cells were
cultured for 8–10 days with fresh media added on days 3, 6, and 8. BMDCs
were harvested and replated in complete RPMI with or without GMCSF for
stimulation. Alternatively, CD11c+ BMDCs were purified with magnetic
particles.
ELISA and Cytometric Bead Array
Bloodwas collected from tail vein or cardiac puncture, and different proteins in
the serum were analyzed by sandwich ELISA. The levels of Flt3L (R&D Sys-
tems), TNF-a, and IL-1b (ebioscience) were determined using ELISA kits. Addi-
tionally, multiple cytokines were quantitated with the mouse inflammation
cytometric bead array kit (BD Biosciences). Samples were collected on the
LSR II and analyzed with FCAP Array Software (BD Biosciences).
Cell Death Induction
To examine cell death in dendritic cells, cells were pretreated with 10 mM
zVAD-FMK and/or 30 mM necrostatin-1 for 30 min and then stimulated with
10 ng/ml LPS or 100 ng/ml recombinant TNF-a at 37C. Following 16–18 hr
of stimulation, BMDCs were harvested in cold PBS and surface stained with
anti-CD11c and anti-CD11b in fluorescence-activated cell sorting buffer. Cells
were then washed in Annexin V binding buffer and labeled with fluorescein iso-
thiocyanate-Annexin V and 7AAD. Samples were analyzed by flow cytometry.
Statistical Analysis
Statistical significance was calculated using paired or unpaired Student’s
t test. Mann-Whitney U test was used to compare survival curves. Statistical
analysis was completed with GraphPad Prism (GraphPad). For reagents and
additional method details, please refer to the Extended Experimental
Procedures.
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